Retrospective analysis of the teeth that were treated for vital bleaching in relation to age and gender

Ishwarya S; Dr. S. Pradeep; Dr. Lakshmi Praba

doi:10.69980/redvet.v25i1.2456

Ishwarya S
Dr. S. Pradeep
Dr. Lakshmi Praba

DOI: https://doi.org/10.69980/redvet.v25i1.2456

Keywords: Vital bleaching,Teeth whitening,Tooth shade,Dental aesthetics,Age,GenderRetrospective analysis,Tooth sensitivity,Side effects,Patient satisfaction,Personalized treatment,Dental records,Shade change,Dental shade guide,Gender differences

Abstract

INTRODUCTION

This is a case of vital bleaching which is another commonly used cosmetic dental option to make an improvement to teeth that appear darker than desired. It is an increasingly popular procedure over the years, among patients who wish their teeth were brighter and whiter. The therapy was effective as it improved teeth aesthetics, enhancing their users’ self-confidence and social interaction.

AIM AND OBJECTIVE

The aim of this study is to analyze the Retrospective analysis of the teeth that were treated for vital bleaching in relation to age and gender

MATERIALS AND METHODS

Obtain access to dental records or electronic databases containing information on patients who underwent vital bleaching treatments.

We have extracted the data for each patients like patient ID, age at the time of treatment, gender, pre-treatment tooth shade, post-treatment tooth shade, treatment date, and any reported side effects or tooth sensitivity

CONCLUSION

However, retrospective assessment on teeth used for vital bleaching with regard to age and gender showed varying clinical results. This research revealed that the bleaching process performed more effectively on younger as opposed to old individuals.

Author Biographies

Ishwarya S

Bachelor in dental surgery, Saveetha dental college and hospitals, Saveetha Institute of Medical and Technical sciences, Chennai, India

Dr. S. Pradeep

Professor, Department of Endodontics and Conservative Dentistry, Saveetha Dental College, Chennai.

Dr. Lakshmi Praba

Professor, Department of Endodontics and Conservative Dentistry, Saveetha Dental College, Chennai.

References

1. Almeida, L.Y. de et al. (2023) ‘FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1’, Oral diseases, 29(2), pp. 649–660.
2. Blumenthal, R.D. (2008) Chemosensitivity: Volume I: In Vitro Assays. Springer Science & Business Media.
3. Bocci, G. and Francia, G. (2014) Metronomic Chemotherapy: Pharmacology and Clinical Applications. Springer.
4. Carcinogen-Driven Mouse Models of Oncogenesis (2021). Academic Press.
5. Choi, H.S. et al. (2020) ‘Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines’, International journal of molecular sciences, 21(23). Available at: https://doi.org/10.3390/ijms21238897.
6. ‘Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC)’ (2022) Oral oncology, 126, p. 105763.
7. ‘Expression analysis of transforming growth factor beta (TGF-β) in oral squamous cell carcinoma’ (2024) Oral Oncology Reports, 9, p. 100195.
8. Fribley, A. (2016) Targeting Oral Cancer. Springer.
9. Han, H.-Y. et al. (2016) ‘Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors’, Journal of ethnopharmacology, 192, pp. 431–441.
10. Kii, T., Sakuma, K. and Tanaka, A. (2021a) ‘Optimal Contact Concentration of Paclitaxel in the Collagen Gel Droplet-Embedded Culture Drug Sensitivity Test for Human Oral Squamous Cell Carcinoma and Evaluation of Combination with Cetuximab’, Chemotherapy, 65(5-6), pp. 147–157.
11. Kii, T., Sakuma, K. and Tanaka, A. (2021b) ‘PTEN Is Activated by the Addition of Cetuximab to Paclitaxel in Oral Squamous Cell Carcinoma’, Anticancer research, 41(7), pp. 3363–3370.
12. Kumar, V.B. et al. (2021) ‘7-Epitaxol Induces Apoptosis and Autophagy in Head and Neck Squamous Cell Carcinoma through Inhibition of the ERK Pathway’, Cells , 10(10). Available at: https://doi.org/10.3390/cells10102633.
13. Mallery, S.R. et al. (2019) ‘Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention’, Molecular cancer therapeutics, 18(12), pp. 2308–2320.
14. Meng, X. et al. (2021) ‘The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential’, Cancer communications, 41(10), pp. 981–1006.
15. Panta, P. (2019) Oral Cancer Detection: Novel Strategies and Clinical Impact. Springer.
16. Parsons, R.A. (2007) Progress in Cancer Drug Resistance Research. Nova Publishers.
17. Reinhold, U. and Tilgen, W. (2002) Chemosensitivity Testing in Oncology. Springer Science & Business Media.
18. ‘Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics’ (2022) Oral oncology, 125, p. 105713.
19. Sawatani, Y. et al. (2020) ‘Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro’, International journal of molecular sciences, 21(17). Available at: https://doi.org/10.3390/ijms21176292.
20. September 2021 - Volume 74 - Issue 3 : Hepatology (no date). Available at: https://journals.lww.com/hep/toc/2021/09000 (Accessed: 9 February 2024).
21. Song, J.M. et al. (2019) ‘Oral Administration of , a Major Pathogen of Chronic Periodontitis, Promotes Resistance to Paclitaxel in Mouse Xenografts of Oral Squamous Cell Carcinoma’, International journal of molecular sciences, 20(10). Available at: https://doi.org/10.3390/ijms20102494.
22. Wasan, K.M. and Badea, I. (2019) Drug Delivery Technology Development in Canada. MDPI.
23. Yuzhalin, A. and Kutikhin, A. (2014) Interleukins in Cancer Biology: Their Heterogeneous Role. Academic Press.